Chinese- REPORT SUMMARY
- TABLE OF CONTENTS
-
This report elaborates on the current development of the Nonalcoholic Fatty Liver Disease industry thoroughly based on the international market dynamics and China's market situation.
For a start, the report provides an in-depth analysis of the current market situation through three different aspects - by region, by type and by application, which includes market distribution of different types and applications, import and export analysis of major regions, development trends of different types of products in each region, market opportunities and market restrains of different applications.
Secondly, this report lists the major players in the industry, displaying their market positions and strengths and weaknesses of their products, picturing the current competitive situation of the whole market.
Last but not least, the report analyzes and predicts the investment prospects and risks in the industry on the basis of industry data, combined with experts' opinions and suggestions.
By Player:
Phenex Pharmaceuticals
Tobira Therapeutics
Novartis AG
Galmed International
Metabolic Solutions Development
Raptor Pharmaceuticals
Conatus Pharmaceuticals
TCM Biotech International
Kyorin Pharmaceutical
By Type:
Type 1
Type 2
Type 3
By Application:
Application 1
Application 2
Application 3
By Research Region:
-
North China
-
Central China
-
South China
-
East China
-
Northeast China
-
Southwest China
-
Northwest China
TABLE OF CONTENT
Chapter 1 China Nonalcoholic Fatty Liver Disease Market Overview 2018-2029
-
1.1 China Nonalcoholic Fatty Liver Disease Industry Development Overview
-
1.2 China Nonalcoholic Fatty Liver Disease Industry Development History
-
1.3 China Nonalcoholic Fatty Liver Disease Industry Market Size (2018-2029)
-
1.4 China Nonalcoholic Fatty Liver Disease Market Analysis by Type from Production Side
-
1.4.1 China Nonalcoholic Fatty Liver Disease Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
1.4.2 China Nonalcoholic Fatty Liver Disease Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
1.4.3 China Nonalcoholic Fatty Liver Disease Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
1.5 China Nonalcoholic Fatty Liver Disease Market Analysis by Application from Consumption End
-
1.5.1 China Nonalcoholic Fatty Liver Disease Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
1.5.2 China Nonalcoholic Fatty Liver Disease Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
1.5.3 China Nonalcoholic Fatty Liver Disease Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
1.6 China Nonalcoholic Fatty Liver Disease Market Analysis by Region
-
1.6.1 North China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
1.6.2 Central China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
1.6.3 South China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
1.6.4 East China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
1.6.5 Northeast China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
1.6.6 Southwest China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
1.6.7 Northwest China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
Chapter 2 China Nonalcoholic Fatty Liver Disease Industry Development Environment
-
2.1 Industry Development Environment Analysis
-
2.1.1 Industry Technological Progress Analysis
-
2.1.2 Industrial Organizational Innovation Analysis
-
2.1.3 Changes in Social Habits
-
2.1.4 Alterations in Government Policies
-
2.1.5 Impact of Economic Globalization
-
2.2 Domestic and Foreign Industry Competition Analysis
-
2.2.1 Comparative Analysis on Nonalcoholic Fatty Liver Disease Market Status and Competition at home and abroad in 2023
-
2.2.2 China Nonalcoholic Fatty Liver Disease Market Status and Competition Analysis in 2023
-
2.2.3 China Nonalcoholic Fatty Liver Disease Market Concentration Analysis in 2023
-
2.3 Problems and Countermeasures in the development of China Nonalcoholic Fatty Liver Disease Industry
-
2.3.1 Industry Development Constraints
-
2.3.2 Industry Development Considerations
-
2.3.3 Suggestions on Industry Development Measures
-
2.3.4 Development Strategies for SMEs
-
2.4 Influence of COVID-19 Outbreak on Nonalcoholic Fatty Liver Disease Industry Development
Chapter 3 Nonalcoholic Fatty Liver DiseaseIndustry Chain Analysis
-
3.1 Nonalcoholic Fatty Liver Disease Industry Chain
-
3.2 Nonalcoholic Fatty Liver Disease Upstream Industry Analysis
-
3.2.1 Upstream Industry Development Status
-
3.2.2 Upstream Industry Development Forecast
-
3.2.3 Impact of Upstream Industry on the Nonalcoholic Fatty Liver Disease Market
-
3.3 Nonalcoholic Fatty Liver Disease Downstream Industry Analysis
-
3.3.1 Downstream Industry Development Status
-
3.3.2 Downstream Industry Development Forecast
-
3.3.3 Impact of Downstream Industry on the Nonalcoholic Fatty Liver Disease Market
Chapter 4 China Nonalcoholic Fatty Liver Disease Market, by Type
-
4.1 China Nonalcoholic Fatty Liver Disease Market Trend, by Type
-
4.2 Product Types of Major Suppliers
-
4.3 Competitive Landscape of Major Types
-
4.4 China Nonalcoholic Fatty Liver Disease Total Production Volume and Growth Rate from Production Side
-
4.5 China Nonalcoholic Fatty Liver Disease Production Volume and Growth Rate, by Type
-
4.5.1 China Nonalcoholic Fatty Liver Disease Production Volume and Growth Rate of Type 1
-
4.5.2 China Nonalcoholic Fatty Liver Disease Production Volume and Growth Rate of Type 2
-
4.5.3 China Nonalcoholic Fatty Liver Disease Production Volume and Growth Rate of Type 3
Chapter 5 China Nonalcoholic Fatty Liver Disease Market, by Application
-
5.1 Downstream Market Overview
-
5.2 Competitive Landscape of Major Applications
-
5.3 Market Potential Analysis, by Application
-
5.4 China Nonalcoholic Fatty Liver Disease Total Market Size and Growth Rate from Consumption End
-
5.5 China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate, by Application
-
5.5.1 China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate of Application 1
-
5.5.2 China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate of Application 2
-
5.5.3 China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate of Application 3
Chapter 6 China Nonalcoholic Fatty Liver Disease Market, by Region
-
6.1 China Nonalcoholic Fatty Liver Disease Production Volume and Production Value, by Region
-
6.2 China Nonalcoholic Fatty Liver Disease Sales Volume and Sales Value, by Region
Chapter 7 North China Nonalcoholic Fatty Liver Disease Market Analysis
-
7.1 North China Nonalcoholic Fatty Liver Disease Market, by Type
-
7.2 North China Nonalcoholic Fatty Liver Disease Market, by Application
Chapter 8 Central China Nonalcoholic Fatty Liver Disease Market Analysis
-
8.1 Central China Nonalcoholic Fatty Liver Disease Market, by Type
-
8.2 Central China Nonalcoholic Fatty Liver Disease Market, by Application
Chapter 9 South China Nonalcoholic Fatty Liver Disease Market Analysis
-
9.1 South China Nonalcoholic Fatty Liver Disease Market, by Type
-
9.2 South China Nonalcoholic Fatty Liver Disease Market, by Application
Chapter 10 East China Nonalcoholic Fatty Liver Disease Market Analysis
-
10.1 East China Nonalcoholic Fatty Liver Disease Market, by Type
-
10.2 East China Nonalcoholic Fatty Liver Disease Market, by Application
Chapter 11 Northeast China Nonalcoholic Fatty Liver Disease Market Analysis
-
11.1 Northeast China Nonalcoholic Fatty Liver Disease Market, by Type
-
11.2 Northeast China Nonalcoholic Fatty Liver Disease Market, by Application
Chapter 12 Southwest China Nonalcoholic Fatty Liver Disease Market Analysis
-
12.1 Southwest China Nonalcoholic Fatty Liver Disease Market, by Type
-
12.2 Southwest China Nonalcoholic Fatty Liver Disease Market, by Application
Chapter 13 Northwest China Nonalcoholic Fatty Liver Disease Market Analysis
-
13.1 Northwest China Nonalcoholic Fatty Liver Disease Market, by Type
-
13.2 Northwest China Nonalcoholic Fatty Liver Disease Market, by Application
Chapter 14 Company Profiles
-
14.1 Phenex Pharmaceuticals
-
14.1.1 Phenex Pharmaceuticals Company Profile
-
14.1.2 Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Market Performance
-
14.1.3 Product&Service Introduction
-
14.2 Tobira Therapeutics
-
14.2.1 Tobira Therapeutics Company Profile
-
14.2.2 Tobira Therapeutics Nonalcoholic Fatty Liver Disease Market Performance
-
14.2.3 Product&Service Introduction
-
14.3 Novartis AG
-
14.3.1 Novartis AG Company Profile
-
14.3.2 Novartis AG Nonalcoholic Fatty Liver Disease Market Performance
-
14.3.3 Product&Service Introduction
-
14.4 Galmed International
-
14.4.1 Galmed International Company Profile
-
14.4.2 Galmed International Nonalcoholic Fatty Liver Disease Market Performance
-
14.4.3 Product&Service Introduction
-
14.5 Metabolic Solutions Development
-
14.5.1 Metabolic Solutions Development Company Profile
-
14.5.2 Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Market Performance
-
14.5.3 Product&Service Introduction
-
14.6 Raptor Pharmaceuticals
-
14.6.1 Raptor Pharmaceuticals Company Profile
-
14.6.2 Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Market Performance
-
14.6.3 Product&Service Introduction
-
14.7 Conatus Pharmaceuticals
-
14.7.1 Conatus Pharmaceuticals Company Profile
-
14.7.2 Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Market Performance
-
14.7.3 Product&Service Introduction
-
14.8 TCM Biotech International
-
14.8.1 TCM Biotech International Company Profile
-
14.8.2 TCM Biotech International Nonalcoholic Fatty Liver Disease Market Performance
-
14.8.3 Product&Service Introduction
-
14.9 Kyorin Pharmaceutical
-
14.9.1 Kyorin Pharmaceutical Company Profile
-
14.9.2 Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Market Performance
-
14.9.3 Product&Service Introduction
Chapter 15 Research Conclusions and Investment Suggestions
-
15.1 Nonalcoholic Fatty Liver Disease Industry Research Conclusions
-
15.2 Nonalcoholic Fatty Liver Disease Industry Investment Suggestions
-
15.2.1 Suggestions on Industry Development Strategy
-
15.2.2 Suggestions on Industry Investment Direction
-
15.2.3 Suggestions on Industry Investment Strategy
List of Tables and Figures
-
Figure China Nonalcoholic Fatty Liver Disease Industry Market Size (2018-2029)
-
Figure China Nonalcoholic Fatty Liver Disease Production Volume, Production Value and Growth Rate of Type 1 (2018-2029)
-
Figure China Nonalcoholic Fatty Liver Disease Production Volume, Production Value and Growth Rate of Type 2 (2018-2029)
-
Figure China Nonalcoholic Fatty Liver Disease Production Volume, Production Value and Growth Rate of Type 3 (2018-2029)
-
Figure China Nonalcoholic Fatty Liver Disease Sales Volume, Sales Value and Growth Rate of Application 1 (2018-2029)
-
Figure China Nonalcoholic Fatty Liver Disease Sales Volume, Sales Value and Growth Rate of Application 2 (2018-2029)
-
Figure China Nonalcoholic Fatty Liver Disease Sales Volume, Sales Value and Growth Rate of Application 3 (2018-2029)
-
Figure North China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
Figure Central China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
Figure South China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
Figure East China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
Figure Northeast China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
Figure Southwest China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
Figure Northwest China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate from 2018-2029
-
Figure Nonalcoholic Fatty Liver Disease Industry Chain
-
Table Product Types of Major Suppliers in 2023
-
Figure China Nonalcoholic Fatty Liver Disease Market Share by Type in 2018
-
Figure China Nonalcoholic Fatty Liver Disease Market Share by Type in 2023
-
Figure China Nonalcoholic Fatty Liver Disease Total Production Volume and Growth Rate from Production Side (2018-2023)
-
Figure China Nonalcoholic Fatty Liver Disease Production Volume and Growth Rate of Type 1 (2018-2023)
-
Figure China Nonalcoholic Fatty Liver Disease Production Volume and Growth Rate of Type 2 (2018-2023)
-
Figure China Nonalcoholic Fatty Liver Disease Production Volume and Growth Rate of Type 3 (2018-2023)
-
Figure China Nonalcoholic Fatty Liver Disease Market Share by Application in 2018
-
Figure China Nonalcoholic Fatty Liver Disease Market Share by Application in 2023
-
Figure China Nonalcoholic Fatty Liver Disease Total Market Size and Growth Rate from Consumption End
-
Figure China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate of Application 1 (2018-2023)
-
Figure China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate of Application 2 (2018-2023)
-
Figure China Nonalcoholic Fatty Liver Disease Market Size and Growth Rate of Application 3 (2018-2023)
-
Table China Nonalcoholic Fatty Liver Disease Production Volume by Region (2018-2023)
-
Table China Nonalcoholic Fatty Liver Disease Production Volume Share by Region (2018-2023)
-
Figure China Nonalcoholic Fatty Liver Disease Production Volume Share by Region (2018-2023)
-
Table China Nonalcoholic Fatty Liver Disease Production Value by Region (2018-2023)
-
Table China Nonalcoholic Fatty Liver Disease Production Value Share by Region (2018-2023)
-
Figure China Nonalcoholic Fatty Liver Disease Production Value Share by Region (2018-2023)
-
Table China Nonalcoholic Fatty Liver Disease Sales Volume by Region (2018-2023)
-
Table China Nonalcoholic Fatty Liver Disease Sales Volume Share by Region (2018-2023)
-
Figure China Nonalcoholic Fatty Liver Disease Sales Volume Share by Region (2018-2023)
-
Table China Nonalcoholic Fatty Liver Disease Sales Value by Region (2018-2023)
-
Table China Nonalcoholic Fatty Liver Disease Sales Value Share by Region (2018-2023)
-
Figure China Nonalcoholic Fatty Liver Disease Sales Value Share by Region (2018-2023)
-
Table North China Nonalcoholic Fatty Liver Disease Production Volume by Type (2018-2023)
-
Table North China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Figure North China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Table North China Nonalcoholic Fatty Liver Disease Sales Volume by Application (2018-2023)
-
Table North China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Figure North China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Table Central China Nonalcoholic Fatty Liver Disease Production Volume by Type (2018-2023)
-
Table Central China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Figure Central China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Table Central China Nonalcoholic Fatty Liver Disease Sales Volume by Application (2018-2023)
-
Table Central China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Figure Central China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Table South China Nonalcoholic Fatty Liver Disease Production Volume by Type (2018-2023)
-
Table South China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Figure South China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Table South China Nonalcoholic Fatty Liver Disease Sales Volume by Application (2018-2023)
-
Table South China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Figure South China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Table East China Nonalcoholic Fatty Liver Disease Production Volume by Type (2018-2023)
-
Table East China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Figure East China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Table East China Nonalcoholic Fatty Liver Disease Sales Volume by Application (2018-2023)
-
Table East China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Figure East China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Table Northeast China Nonalcoholic Fatty Liver Disease Production Volume by Type (2018-2023)
-
Table Northeast China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Figure Northeast China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Table Northeast China Nonalcoholic Fatty Liver Disease Sales Volume by Application (2018-2023)
-
Table Northeast China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Figure Northeast China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Table Southwest China Nonalcoholic Fatty Liver Disease Production Volume by Type (2018-2023)
-
Table Southwest China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Figure Southwest China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Table Southwest China Nonalcoholic Fatty Liver Disease Sales Volume by Application (2018-2023)
-
Table Southwest China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Figure Southwest China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Table Northwest China Nonalcoholic Fatty Liver Disease Production Volume by Type (2018-2023)
-
Table Northwest China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Figure Northwest China Nonalcoholic Fatty Liver Disease Production Volume Share by Type (2018-2023)
-
Table Northwest China Nonalcoholic Fatty Liver Disease Sales Volume by Application (2018-2023)
-
Table Northwest China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Figure Northwest China Nonalcoholic Fatty Liver Disease Sales Volume Share by Application (2018-2023)
-
Table Phenex Pharmaceuticals Company Profile
-
Table Phenex Pharmaceuticals Nonalcoholic Fatty Liver Disease Revenue, Price and Gross (2018-2023)
-
Table Tobira Therapeutics Company Profile
-
Table Tobira Therapeutics Nonalcoholic Fatty Liver Disease Revenue, Price and Gross (2018-2023)
-
Table Novartis AG Company Profile
-
Table Novartis AG Nonalcoholic Fatty Liver Disease Revenue, Price and Gross (2018-2023)
-
Table Galmed International Company Profile
-
Table Galmed International Nonalcoholic Fatty Liver Disease Revenue, Price and Gross (2018-2023)
-
Table Metabolic Solutions Development Company Profile
-
Table Metabolic Solutions Development Nonalcoholic Fatty Liver Disease Revenue, Price and Gross (2018-2023)
-
Table Raptor Pharmaceuticals Company Profile
-
Table Raptor Pharmaceuticals Nonalcoholic Fatty Liver Disease Revenue, Price and Gross (2018-2023)
-
Table Conatus Pharmaceuticals Company Profile
-
Table Conatus Pharmaceuticals Nonalcoholic Fatty Liver Disease Revenue, Price and Gross (2018-2023)
-
Table TCM Biotech International Company Profile
-
Table TCM Biotech International Nonalcoholic Fatty Liver Disease Revenue, Price and Gross (2018-2023)
-
Table Kyorin Pharmaceutical Company Profile
-
Table Kyorin Pharmaceutical Nonalcoholic Fatty Liver Disease Revenue, Price and Gross (2018-2023)
-
